−0.0348USD
−221.10 KUSD
184.49 KUSD
3.54 M
About ENTHEON BIOMEDICAL CORP.
Sector
CEO
Timothy Ko
Headquarters
Vancouver
Website
Founded
2010
FIGI
BBG00Y73P0H5
Entheon Biomedical Corp. is a biotechnology company, which engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ENTBF is 0.1310 USD — it has decreased by 10.64% in the past 24 hours. Watch ENTHEON BIOMEDICAL CORP. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange ENTHEON BIOMEDICAL CORP. stocks are traded under the ticker ENTBF.
ENTBF stock has risen by 18.02% compared to the previous week, the month change is a 18.87% rise, over the last year ENTHEON BIOMEDICAL CORP. has showed a 21.08% decrease.
ENTBF reached its all-time high on Jan 22, 2021 with the price of 20.0000 USD, and its all-time low was 0.0430 USD and was reached on Dec 28, 2023. View more price dynamics on ENTBF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ENTBF stock is 32.07% volatile and has beta coefficient of −0.12. Track ENTHEON BIOMEDICAL CORP. stock price on the chart and check out the list of the most volatile stocks — is ENTHEON BIOMEDICAL CORP. there?
Today ENTHEON BIOMEDICAL CORP. has the market capitalization of 651.35 K, it has increased by 34.11% over the last week.
Yes, you can track ENTHEON BIOMEDICAL CORP. financials in yearly and quarterly reports right on TradingView.
ENTBF net income for the last quarter is −55.11 K USD, while the quarter before that showed −54.22 K USD of net income which accounts for −1.66% change. Track more ENTHEON BIOMEDICAL CORP. financial stats to get the full picture.
No, ENTBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENTHEON BIOMEDICAL CORP. EBITDA is −205.99 K USD, and current EBITDA margin is −124.96%. See more stats in ENTHEON BIOMEDICAL CORP. financial statements.
Like other stocks, ENTBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENTHEON BIOMEDICAL CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENTHEON BIOMEDICAL CORP. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENTHEON BIOMEDICAL CORP. stock shows the sell signal. See more of ENTHEON BIOMEDICAL CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.